tiprankstipranks
Trending News
More News >
GlaxoSmithKline (GSK)
NYSE:GSK
US Market

GlaxoSmithKline (GSK) Technical Analysis

Compare
4,988 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
GlaxoSmithKline’s (GSK) Moving Averages Convergence Divergence (MACD) indicator is 1.06, suggesting GlaxoSmithKline is a Sell.
GlaxoSmithKline’s (GSK) 20-Day exponential moving average is 39.23, while GlaxoSmithKline’s (GSK) share price is $41.15, making it a Buy.
GlaxoSmithKline’s (GSK) 50-Day exponential moving average is 38.04, while GlaxoSmithKline’s (GSK) share price is $41.15, making it a Buy.

GlaxoSmithKline (GSK) Pivot Points

Jun 07, 2025, 02:43 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
40.15
40.35
40.57
40.77
40.99
41.19
41.41
Fibonacci
40.35
40.51
40.61
40.77
40.93
41.03
41.19
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GlaxoSmithKline (GSK) Moving Averages

Jun 07, 2025, 02:43 AM
Period
Simple
Exponential
MA5
41.02Buy
40.76Buy
MA10
40.13Buy
40.16Buy
MA20
38.62Buy
39.23Buy
MA50
37.45Buy
38.04Buy
MA100
36.82Buy
37.28Buy
MA200
36.77Buy
37.19Buy
GlaxoSmithKline’s (GSK) 10-Day exponential moving average is 40.16, while GlaxoSmithKline’s (GSK) share price is $41.15, making it a Buy.
GlaxoSmithKline’s (GSK) 100-Day exponential moving average is 37.28, while GlaxoSmithKline’s (GSK) share price is $41.15, making it a Buy.
GlaxoSmithKline’s (GSK) stock price is $41.15 and GlaxoSmithKline’s (GSK) 50-day simple moving average is 37.45, creating a Buy signal.
GlaxoSmithKline’s (GSK) stock price is $41.15 and GlaxoSmithKline’s (GSK) 100-day simple moving average is 36.82, creating a Buy signal.
GlaxoSmithKline’s (GSK) stock price is $41.15 and GlaxoSmithKline’s (GSK) 200-day simple moving average is 36.77, creating a Buy signal.

GlaxoSmithKline (GSK) Technical Indicators

Jun 07, 2025, 02:43 AM
Name
Value
Implied Action
RSI (14)
65.30
Neutral
STOCH (9,6)
73.96
Neutral
STOCHRSI (14)
83.58
Sell
MACD (12,26)
1.06
Sell
ADX (14)
25.29
Neutral
Williams %R
-11.16
Sell
CCI (14)
117.60
Sell
ATR (14)
0.86
-
Ultimate Oscillator
60.69
Neutral
ROC
10.77
Buy
GlaxoSmithKline’s (GSK) Relative Strength Index (RSI) is 65.30, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Trend Strength Indicator (ADX) is 25.29, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Commodity Channel Index (CCI) is 117.60, creating a Sell signal.
GlaxoSmithKline’s (GSK) Price Rate of Change (ROC) is 10.77, creating a Buy signal.

FAQ

Is GSK a Buy, Hold, or Sell?
Based on GSK’s technical indicators, GSK is a Buy.
    What is GSK’s RSI (14)?
    GSK’s RSI (14) is 65.30, which suggests GSK is a Neutral.
      What is GSK’s MACD?
      GSK’s MACD is 1.06, which suggests GSK is a Sell.
        What is GSK’s 5-day moving average?
        GSK’s 5-day moving average is 41.02, which suggests GSK is a Buy.
          What is GSK’s 20-day moving average?
          GSK 20-day moving average is 38.62, which suggests GSK is a Buy.
            What is GSK’s 50-day moving average?
            GSK’s 50-day moving average is 37.45, which suggests GSK is a Buy.
              What is GSK’s 200-day moving average?
              GSK’s 200-day moving average is 36.77, which suggests GSK is a Buy.
                What is GSK’s Williams % R (14)?
                GSK’s Williams % R (14) is -11.16, which suggests GSK is a Sell.
                  What is GSK’s CCI (14)?
                  GSK’s CCI (14) is 117.60, which suggests GSK is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis